ICU Medical (ICUI) - EV/EBITDA Multiple

ICU Medical Inc. - graphic logo of issuer ICUI

Stable consumables procurement creates a defensive barrier for ICU Medical, Inc. (ICUI), although the EV/EBITDA leverage and operational load metric demonstrates sensitivity to credit shocks. Experienced management is currently optimizing logistics, while the implementation of AI control and robotic catheter assembly reduces costs. The value of 14.40 expresses the current metric value, confirming the business's market value relative to its operating profit.

ICUI ICU Medical Corp: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/11/2026
Manufactured products of ICU Medical

This indicator compares the total enterprise value, including net debt, with EBITDA, allowing for the determination of a fair risk premium and the speed of capital revaluation. The EV/EBITDA trend for ICU Medical, Inc. (ICUI) is critical when analyzing the impact of raw material costs and legal expenses on margins, confirming the company's resilience to healthcare sector budget constraints.

Competitors of ICU Medical, Inc.

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation XRAY|LMAT: Enterprise Value to EBITDA Ratio|ATRC - EV/EBITDA Multiple|STAAR Surgical Company (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex|ZIMV (ZimVie) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus Corp (CERS)|Teknova Inc - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology Inc)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products Inc. UTMD|KRMD: EV/EBITDA Multiple|NYXH - Total Company Value to Operating Income Before Depreciation Ratio|MBOT (Microbot Medical Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio pro-dex.com (PDEX)|Enterprise Value to EBITDA Ratio ZTEK (Zentek)|EV/EBITDA Multiple Elutia Inc (ELUT)|Milestone Scientific Corp - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation NXGL|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Harvard Bioscience Inc. (HBIO) - Enterprise Value to EBITDA Ratio|FEMY: EV/EBITDA Multiple|Company Value to EBITDA Meihua Medical Technologies Co., Ltd. (MHUA)|POAI (Predictive Oncology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CJMB (Callan JMB Corp)|EV/EBITDA Multiple ATRI|Total Company Value to Operating Income Before Depreciation Ratio neurometrix.com